Malignant Intestinal Neoplasm — Trials

Malignant Intestinal Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

7,773 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,666
Recruiting: 939
Ph III recruiting: 109
Growth YoY: +12.2%
Industry share: 21%
Top sponsor: Fudan University
Termination share: 25.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (772)

clinicaltrialsPublishedShowing 301–350 of 7,773 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05672316	Botensilimab, Balstilimab and Regorafenib for the Treatment of Patients With Microsatellite Stable Metastatic Colorectal Cancer Who Have Progressed on Prior Chemotherapy	active not recruiting	Phase 1 / Phase 2	28	City of Hope Medical CenterOTHER	1	Sep 1, 2026	clinicaltrials
NCT06992258	A Randomized Phase 2 Trial of Fruquintinib and TAS-102 as Compared to Fruquintinib in Patients With Refractory Advanced/Metastatic Colorectal Cancer(FRUITION)	recruiting	Phase 2	120	Criterium, Inc.INDUSTRY